Skip to main content

News Flash: NCS Annual Meeting - SAHRANG: Subarachnoid Hemorrhage Recovery and Galantamine- A pilot multicenter randomized placebo controlled trial

Loading audio, please wait...


Dr. Andrew Bauerschmidt interviews Dr. H. Alex Choi about his presentation, "SAHRANG: Subarachnoid Hemorrhage Recovery and Galantamine- A pilot multicenter randomized placebo controlled trial" from the NCS Annual Meeting.

The NCS Podcast is the official podcast of the Neurocritical Care Society. Our senior producer is Bonnie Rossow. Our host is Fawaz Almufti, and our production staff includes Tareq Saad Almaghrabi, Andrew Bauerschmidt, Leonid Groysman, Atul Kalanuria, Lauren Koffman, Kassi Kronfeld, Holly Ledyard, Lindsay Marchetti, Alexandra Reynolds, Lucia Rivera Lara, Jon Rosenberg, Jason Siegel, Zachary Threlkeld, Teddy Youn, and Chris Zammit. Our administrative staff includes Bonnie Rossow. Music by Mohan Kottapally.


  • H. Alex Choi, MD

    H. Alex Choi, M.D. is an Assistant Professor and neurointensivist at McGovern Medical School at UTHealth. His work focuses on research that improves patient outcomes after acute brain injury, particularly aneurysmal Subarachnoid Hemorrhage (SAH). He is interested in employing statistical, informatics and machine learning approaches to addresses some critical problems in the Neuroscience Intensive Care Unit (NICU). Major research interests focus on (a) prediction of secondary complications such as delayed cerebral ischemia (DCI) after SAH (b) understanding abnormal neuroinflammatory activity after acute brain injury and their association with poor outcomes. Currently, the lab is focused on using network informatics approaches to model and analyze the immune profile. The immune response is complex and dynamic involving hundreds of interactions and cells and molecules. Conventional statistical methods fail to account for this intricacy. The novel bioinformatics tools developed will seek to unravel this complexity and provide deeper insights into the nature of the immune profile and (c) Clinical research/trials pertaining to SAH; working in concert with labs (Dr.Pramod Dash) involved in preclinical research to test novel anti-inflammatory therapeutics after acute brain injury.